Clinical Trial Update: Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating amifostine for chemotherapy-induced peripheral neuropathy; the study involving patients with various cancers, including gestational tro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Tumor
• Peripheral Neuropathy

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Gestational Trophoblastic Tumor, Neurotoxicity | Phase 3 | Status: COMPLETED